Phosphodiesterase 4B2 gene is an effector of Toll-like receptor signaling in astrocytes

Metabolic Brain Disease

Volumn 24, Issue 3, 2009, Pages 481-491

  Borysiewicz, Elizabeth ^a   Fil, Daniel ^a   Dlaboga, Daniel ^a   O'Donnell, James M ^a   Konat, Gregory W ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CAMP; Neuroinflammation; Rho protein; Toxin B

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN B; CYCLIC AMP; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; MESSENGER RNA; PHOSPHODIESTERASE 4A; PHOSPHODIESTERASE 4B; PHOSPHODIESTERASE 4D; PHOSPHODIESTERASE IV; POLYINOSINIC POLYCYTIDYLIC ACID; RHO FACTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DOWN REGULATION; EFFECTOR CELL; GENE; GENE EXPRESSION; INFLAMMATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHOSPHODIESTERASE 4B2 GENE; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ASTROCYTES; BLOTTING, WESTERN; CLOSTRIDIUM BOTULINUM TYPE B; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; FEMALE; GENETIC VARIATION; INTERFERON REGULATORY FACTOR-3; ISOENZYMES; MYELOID DIFFERENTIATION FACTOR 88; PREGNANCY; RATS; RATS, INBRED LEW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTORS;

CLOSTRIDIUM DIFFICILE; RATTUS;

EID: 70350018358     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11011-009-9150-9     Document Type: Article

References (34)

1. S Akira K Takeda 2004 Toll-like receptor signalling Nat Rev Immunol 4 499 511 10.1038/nri1391 15229469
2. S Akira S Uematsu O Takeuchi 2006 Pathogen recognition and innate immunity Cell 124 783 801 10.1016/j.cell.2006.02.015 16497588 (Pubitemid 43261452)
3. SL Bailey PA Carpentier EJ McMahon WS Begolka SD Miller 2006 Innate and adaptive immune responses of the central nervous system Crit Rev Immunol 26 149 188 16700651
4. PJ Barnes 2003 New concepts in chronic obstructive pulmonary disease Annu Rev Med 54 113 129 10.1146/annurev.med.54.101601.152209 12359824 (Pubitemid 37386387)
5. MS Barnette DC Underwood 2000 New phosphodiesterase inhibitors as therapeutics for the treatment of chronic lung disease Curr Opin Pulm Med 6 164 169 10.1097/00063198-200003000-00014 10741778
6. A Blokland R Schreiber J Prickaerts 2006 Improving memory: a role for phosphodiesterases Curr Pharm Des 12 2511 2523 10.2174/138161206777698855 16842174
7. GB Bolger L Rodgers M Riggs 1994 Differential CNS expression of alternative mRNA isoforms of the mammalian genes encoding cAMP-specific phosphodiesterases Gene 149 237 244 10.1016/0378-1119(94)90155-4 7958996 (Pubitemid 24361910)
8. P Boquet 1999 Bacterial toxins inhibiting or activating small GTP-binding proteins Ann N Y Acad Sci 886 83 90 10.1111/j.1749-6632.1999.tb09403.x 10667206
9. E Borysiewicz D Fil GW Konat 2009 Rho proteins are negative regulators of TLR2, TLR3 and TLR4 signaling in astrocytes J Neurosci Res 87 1565 1572 10.1002/jnr.21968 19115402
10. M Conti SL Jin 1999 The molecular biology of cyclic nucleotide phosphodiesterases Prog Nucleic Acid Res Mol Biol 63 1 38 10.1016/S0079-6603(08) 60718-7 10506827
11. D Dlaboga H Hajjhussein JM O'Donnell 2008 Chronic haloperidol and clozapine produce different patterns of effects on phosphodiesterase-1B, -4B, and -10A expression in rat striatum Neuropharmacology 54 745 754 10.1016/j.neuropharm.2007.12.002 18222493
12. KL Dodge S Khouangsathiene MS Kapiloff R Mouton EV Hill MD Houslay LK Langeberg JD Scott 2001 mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module EMBO J 20 1921 1930 10.1093/emboj/20.8. 1921 11296225 (Pubitemid 32397394)
13. Y Dong EN Benveniste 2001 Immune function of astrocytes Glia 36 180 190 10.1002/glia.1107 11596126 (Pubitemid 33055906)
14. C D'Sa LM Tolbert M Conti RS Duman 2002 Regulation of cAMP-specific phosphodiesterases type 4B and 4D (PDE4) splice variants by cAMP signaling in primary cortical neurons J Neurochem 81 745 757 10.1046/j.1471-4159.2002.00878.x 12065634 (Pubitemid 34809304)
15. H Fan JA Cook 2004 Molecular mechanisms of endotoxin tolerance J Endotoxin Res 10 71 84 10.1179/096805104225003997 15119998 (Pubitemid 38559782)
16. C Farina F Aloisi E Meinl 2007 Astrocytes are active players in cerebral innate immunity Trends Immunol 28 138 145 10.1016/j.it.2007.01.005 17276138 (Pubitemid 46283692)
17. MA Giembycz 2002 Development status of second generation PDE4 inhibitors for asthma and COPD: the story so far Monaldi Arch Chest Dis 57 48 64 12174704
18. MD Houslay M Sullivan GB Bolger 1998 The multienzyme PDE4 cyclic adenosine monophosphate-specific phosphodiesterase family: intracellular targeting, regulation, and selective inhibition by compounds exerting anti-inflammatory and antidepressant actions Adv Pharmacol 44 225 342 10.1016/S1054-3589(08)60128-3 9547887
19. Z Huang Y Ducharme D Macdonald A Robichaud 2001 The next generation of PDE4 inhibitors Curr Opin Chem Biol 5 432 438 10.1016/S1367-5931(00)00224-6 11470607 (Pubitemid 32900516)
20. T Kaisho S Akira 2006 Toll-like receptor function and signaling J Allergy Clin Immunol 117 979 987 10.1016/j.jaci.2006.02.023 16675322
21. GW Konat A Krasowska-Zoladek M Kraszpulski 2008 Statins enhance toll-like receptor 4-mediated cytokine gene expression in astrocytes: implication of Rho proteins in negative feedback regulation J Neurosci Res 86 603 609 10.1002/jnr.21509 17896797 (Pubitemid 351204473)
22. A Krasowska-Zoladek M Banaszewska M Kraszpulski GW Konat 2007 Kinetics of inflammatory response of astrocytes induced by TLR 3 and TLR4 ligation J Neurosci Res 85 205 212 10.1002/jnr.21088 17061254 (Pubitemid 46079810)
23. C Lugnier 2006 Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents Pharmacol Ther 109 366 398 10.1016/j.pharmthera.2005.07.003 16102838 (Pubitemid 43132818)
24. D Ma P Wu RW Egan MM Billah P Wang 1999 Phosphodiesterase 4B gene transcription is activated by lipopolysaccharide and inhibited by interleukin-10 in human monocytes Mol Pharmacol 55 50 57 9882697
25. K Miyake 2007 Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors Semin Immunol 19 3 10 10.1016/j.smim.2006.12. 002 17275324 (Pubitemid 46498750)
26. T Muller P Engels JR Fozard 1996 Subtypes of the type 4 cAMP phosphodiesterases: structure, regulation and selective inhibition Trends Pharmacol Sci 17 294 298 10.1016/0165-6147(96)10035-3 8810876 (Pubitemid 26261894)
27. LA O'Neill AG Bowie 2007 The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling Nat Rev Immunol 7 353 364 10.1038/nri2079 17457343 (Pubitemid 46674493)
28. MN Palfreyman JE Souness 1996 Phosphodiesterase type IV inhibitors Prog Med Chem 33 1 52 10.1016/S0079-6468(08)70302-3 8776940
29. F Sandor M Buc 2005a Toll-like receptors. I. Structure, function and their ligands Folia Biol (Praha) 51 148 157
30. F Sandor M Buc 2005 Toll-like receptors. II. Distribution and pathways involved in TLR signalling Folia Biol (Praha) 51 188 197
31. M Shepherd T McSorley AE Olsen LA Johnston NC Thomson GS Baillie MD Houslay GB Bolger 2003 Molecular cloning and subcellular distribution of the novel PDE4B4 cAMP-specific phosphodiesterase isoform Biochem J 370 429 438 10.1042/BJ20021082 12441002 (Pubitemid 36315131)
32. KA Tasken P Collas WA Kemmner O Witczak M Conti K Tasken 2001 Phosphodiesterase 4D and protein kinase a type II constitute a signaling unit in the centrosomal area J Biol Chem 276 21999 22002 10.1074/jbc.C000911200 11285255
33. TJ Torphy 1998 Phosphodiesterase isozymes: molecular targets for novel antiasthma agents Am J Respir Crit Care Med 157 351 370 9476844
34. P Wang P Wu KM Ohleth RW Egan MM Billah 1999 Phosphodiesterase 4B2 is the predominant phosphodiesterase species and undergoes differential regulation of gene expression in human monocytes and neutrophils Mol Pharmacol 56 170 174 10385698